Hasegawa Toru, Kamada Yasuhiko, Hosoya Takeshi, Fujita Shiho, Nishiyama Yuki, Iwata Nahoko, Hiramatsu Yuji, Otsuka Fumio
Departments of Obstetrics Gynecology.
Medicine and Clinical Science.
J Steroid Biochem Mol Biol. 2017 Sep;172:160-165. doi: 10.1016/j.jsbmb.2017.07.002. Epub 2017 Jul 4.
Excess androgen and insulin-like growth factor (IGF)-I in the ovarian follicle has been suggested to be involved in the pathophysiology of polycystic ovary syndrome (PCOS). Here we investigated the impact of androgen and IGF-I on the regulatory mechanism of ovarian steroidogenesis using rat primary granulosa cells. It was revealed that androgen treatment with dihydrotestosterone (DHT) amplified progesterone synthesis in the presence of FSH and IGF-I, whereas it had no significant effect on estrogen synthesis by rat granulosa cells. In accordance with the effects of androgen on steroidogenesis, DHT enhanced the expression of progesterogenic factors and enzymes, including StAR, P450scc and 3βHSD, and cellular cAMP synthesis induced by FSH and IGF-I. Of note, treatment with DHT and IGF-I suppressed Smad1/5/8 phosphorylation and transcription of the BMP target gene Id-1, suggesting that androgen and IGF-I counteract BMP signaling that inhibits FSH-induced progesterone synthesis in rat granulosa cells. DHT was revealed to suppress the expression of BMP-6 receptors, consisting of ALK-2, ALK-6 and ActRII, while it increased the expression of inhibitory Smads in rat granulosa cells. In addition, IGF-I treatment upregulated androgen receptor (AR) expression and DHT treatment suppressed IGF-I receptor expression on rat granulosa cells. Collectively, the results indicate that androgen and IGF-I mutually interact and accelerate progesterone production, at least in part, by regulating endogenous BMP signaling in rat granulosa cells. Cooperative effects of androgen and IGF-I counteract endogenous BMP-6 activity in rat granulosa cells, which is likely to be functionally linked to the steroidogenic property shown in the PCOS ovary.
卵巢卵泡中雄激素和胰岛素样生长因子(IGF)-I过多被认为与多囊卵巢综合征(PCOS)的病理生理过程有关。在此,我们使用大鼠原代颗粒细胞研究了雄激素和IGF-I对卵巢类固醇生成调节机制的影响。结果显示,在促卵泡生成素(FSH)和IGF-I存在的情况下,用二氢睾酮(DHT)进行雄激素处理可增强孕酮合成,而对大鼠颗粒细胞的雌激素合成无显著影响。与雄激素对类固醇生成的影响一致,DHT增强了包括类固醇生成急性调节蛋白(StAR)、细胞色素P450侧链裂解酶(P450scc)和3β-羟基类固醇脱氢酶(3βHSD)在内的孕酮生成因子和酶的表达,以及FSH和IGF-I诱导的细胞环磷酸腺苷(cAMP)合成。值得注意的是,用DHT和IGF-I处理可抑制Smad1/5/8磷酸化以及骨形态发生蛋白(BMP)靶基因Id-1的转录,这表明雄激素和IGF-I可抵消抑制大鼠颗粒细胞中FSH诱导的孕酮合成的BMP信号。研究发现,DHT可抑制由激活素受体样激酶2(ALK-2)、激活素受体样激酶6(ALK-6)和激活素受体II(ActRII)组成的BMP-6受体的表达,同时增加大鼠颗粒细胞中抑制性Smads的表达。此外,IGF-I处理可上调雄激素受体(AR)的表达,而DHT处理可抑制大鼠颗粒细胞上IGF-I受体的表达。总体而言,这些结果表明,雄激素和IGF-I相互作用,并至少部分通过调节大鼠颗粒细胞内源性BMP信号来加速孕酮生成。雄激素和IGF-I的协同作用可抵消大鼠颗粒细胞内源性BMP-6的活性,这可能在功能上与PCOS卵巢中表现出的类固醇生成特性相关。